Clinical significance of c-Met expression in patients with advanced gastroesophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
Cancer immunotherapy has transformed the treatment landscape for multiple malignancies; however, its clinical efficacy remains limited in many tumors due to ...
Outcome of TP53-mutated CCUS and the risk of progression to myeloid neoplasms. Jaktinib in patients (pts) with myelofibrosis (MF) who were intolerant to ruxolitinib (RUX): An open-label, single-arm ...